Artículo

Prognostic significance of α‐ and β2‐adrenoceptor gene expression in breast cancer patients

Rivero, Ezequiel MarianoIcon ; Martinez, Leandro MarceloIcon ; Bruque, Carlos DavidIcon ; Gargiulo, LucíaIcon ; Bruzzone, ArianaIcon ; Luthy, Isabel AliciaIcon
Fecha de publicación: 07/2019
Editorial: The British Pharmacological Society
Revista: British Journal Of Clinical Pharmacology
ISSN: 0306-5251
e-ISSN: 1365-2125
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Breast cancer is the most frequently diagnosed and leading cause of cancer death among women worldwide. It was classified within molecular intrinsic subtypes: luminal A, luminal B, human epidermal growth factor receptor 2‐enriched and basal‐like. Epinephrine and norepinephrine, released during stress, bind to adrenoceptors. α2‐adrenoceptors are encoded by the ADRA2A , ADRA2B and ADRA2C genes and β2 by ADRB2 .
Palabras clave: ADRENOCEPTORS , BREAST CANCER PATIENTS , PROGNOSTIC FACTORS
 
Archivos asociados
Thumbnail
 
Tamaño: 5.425Mb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/106323
URL: https://bpspubs.onlinelibrary.wiley.com/journal/13652125
DOI: http://dx.doi.org/10.1111/bcp.14030
Colecciones
Articulos(IBYME)
Articulos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Citación
Rivero, Ezequiel Mariano; Martinez, Leandro Marcelo; Bruque, Carlos David; Gargiulo, Lucía; Bruzzone, Ariana; et al.; Prognostic significance of α‐ and β2‐adrenoceptor gene expression in breast cancer patients; The British Pharmacological Society; British Journal Of Clinical Pharmacology; 85; 9; 7-2019; 2143-2154
Compartir
Altmétricas